The role of chemokines in cutaneous allergic inflammation

Biological Chemistry

Volumn 380, Issue 7-8, 1999, Pages 889-896

  Schröder, Jens Michael ^a   Mochizuki, Mitsuru ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Atopy; Chemokines; Eosinophils; Eotaxin IL 4; RANTES

Indexed keywords

CHEMOKINE; EOTAXIN; INTERLEUKIN 13; INTERLEUKIN 4; RANTES;

ATOPY; CELL STIMULATION; DERMIS; EFFECTOR CELL; EOSINOPHIL; HELPER CELL; PRIORITY JOURNAL; REVIEW; SKIN ALLERGY; SKIN FIBROBLAST;

ANIMALS; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; DERMATITIS, ATOPIC; HUMANS;

EID: 0345062249     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.109     Document Type: Review

References (61)

1. Baggiolini, M. (1998). Chemokines and leukocyte traffic. Nature 392, 565-568.
2. Bartels, J., Schlüter, C., Richter, E., Noso, N., Kulke, R., Christophers, E., and Schröder, J.-M. (1996). Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression, and identification of eotaxin sequence variants. Biochem. Biophys. Res. Commun. 225, 1045-1051.
3. Bradding, P., Feather, I.H., Howarth, P.H., Mueller, R., Roberts, J.A., Britten, K., Bews, J.P.A., Hunt, T.C., Okayama, Y., Heusser, C.H., Bullock, G.R., Church, M.K., and Holgate, S.T. (1992). Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 176, 1381-1386.
4. Brunner, T., Heusser, C.H., and Dahinden, C.A. (1993). Human peripheral blood basophils primed by Interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J. Exp. Med. 177, 605-611.
5. Chensue, S.W., Warmington, K., Ruth, J.H., Lukacs, N., and Kunkel, S.L. (1997). Mycobaterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks. J. Immunol. 159, 3565-3573.
6. Daugherty, B.L., Siciliano, S.J., DeMartino, J.A., Malkowitz, L., Sirotina, A., and Springer, M.S. (1996). Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med. 183, 2349-2354.
7. Elsner, J., Petering, H., Kimmig, D., Wells, T.N., Proudfoot, A.E., and Kapp, A. (1999). The CC chemokine receptor antagonist met-RANTES inhibits eosinophil effector function. Int. Arch. Allergy Immunol. 118, 462-465.
8. Gerber, B.O., Zanni, M.P., Uguccioni, M., Loetscher, M., Mackay, C.R., Pichler, W.J., Yawalkar, N., Baggiolini, M., and Moser, B. (1997). Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr. Biol. 7, 836-843.
9. Goebeler, M., Yoshimura, T., Toksoy, A., Ritter, U., Brocker, E.B., and Gillitzer, R. (1997). The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines. J. Invest. Dermatol. 108, 445-451.
10. Gonzalo, J.A., Lloyd, C.M., Kremer, L., Finger, E., Martinez, A.C., Siegelman, M.H., Cybulsky, M., and Gutierrez-Ramos, J.C. (1996). Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J. Clin. Invest. 98, 2332-2345.
11. Hogaboam, C., Kunkel, S.L., Strieter, R.M., Taub, D.D., Lincoln, P., Standiford, T.J., and Lukacs, N.W. (1998). Novel role of transmembrane SCF for mast cell activation and eotaxin production in mast cell-fibroblast interactions. J. Immunol. 160, 166-171.
12. Holgate, S.T., Robinson, C., and Church, M.K. (1988). The contribution of mast cell mediators to acute allergic reactions in human skin and airways. Allergy 43, 22-31.
13. Jose, P.J., Griffiths-Johnson, D.A., Collins, P.D., Walsh, D.T., Moqbel, R., Totty, N.F., Truong, O., Hsuan, J.J., and Williams, T.J. (1994). Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179, 881-887.
14. Kameyoshi, Y., Dörschner, A., Mallet, A.I., Christophers, E., and Schröder, J.-M. (1992). Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med. 176, 587-592.
15. Kitaura, M., Nakajima, T., Imai, T., Harada, S., Combadiere, C., Tiffany, H.L., Murphy, P.M., and Yoshie, O. (1996). Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J. Biol. Chem. 271, 7725-7730.
16. Kulke, R., Yilmaz, T., Küpper, M., Schlüter, C., Opdenakker, G., Christophers, E., and Schröder, J.-M. (1995). Expression of eosinophil specific chemokines in dermal and epidermal cells. J. Invest. Dermatol. 105, 506. (Abstract).
17. Krüger-Krasagakes, S., Grützkau, A., Lippert, U., and Henz, B.M. (1998). Chemokines and mast cells. In: Chemokines and Skin, S. Kownatzki and J. Norgauer (Basel, Boston, Berlin: Birkhäuser Verlag), pp. 75-87.
18. Lee, B., and Montaner, L.J. (1999). Chemokine immunobiology in HIV-1 pathogenesis. J. Leukoc. Biol. 65, 552-565.
19. Leiferman, K.M. (1991). A current perspective on the role of eosinophils in dermatologic diseases. J. Am. Acad. Dermatol. 24, 1101-1112.
20. Lilly, C.M., Nakamura, H., Kesselman, H., Nagler-Anderson, C., Asano, K., Garcia-Zepeda, E.A., Rothenberg, M.E., Drazen, J.M., and Luster, A.D. (1997). Expression of eotaxin by human lung epithelial cells - Induction by cytokines and inhibition by glucocorticoids. J. Clin. Invest. 99, 1767-1773.
21. Locati, M., and Murphy, P.M. (1999). Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Annu. Rev. Med. 50, 425-440.
22. Loetscher, P., Uguccioni, M., Bordoli, L., Baggiolini, M., Moser, B., Chizzolini, C., and Dayer, J.M. (1998). CCR5 is characteristic of Th1 lymphocytes. Nature 391, 344-345.
23. Lopez, A.F., To, L.B., Yang, Y.C., Gamble, J.R., Shannon, M.F., Burms, G.F., Dyson, P.G., Juttner, C.A., Clark, S., and Vadas, M.A. (1987). Stimulation of proliferation, differentiation, and function of human cells by primate Interleukin 3. Proc. Natl. Acad. Sci. USA 84, 2761-2765.
24. Lopez, A.F., Sanderson, C.J., Gamble, J.R., Campbell, H.D., Young, I.G., and Vadas, M.A. (1988). Recombinant human Interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167, 219-224.
25. Lukacs, N.W., Strieter, R.M., Chensue, S.W., and Kunkel, S.L. (1994). Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma. Am. J. Respir. Cell. Mol. Biol. 10, 526-532.
26. Menten, P., Proost, P., Struyf, S., Van Coillie, E., Put, W., Lenaerts, J.P., Conings, R., Jaspar, J.M., De Groote, D., Billiau, A., Opdenakker, G., and Van Damme, J. (1999). Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-alpha/beta and interferon-gamma revals MCP-3 heterogeneity. Eur. J. Immunol. 29, 678-685.
27. Minshall, E.M., Cameron, L., Lavigne, F., Leung, D.Y., Hamilos, D., Garcia-Zepada, E.A., Rothenberg, M., Luster, A.D., and Hamid, Q. (1997). Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am. J. Respir. Cell. Mol. Biol. 17, 683-690.
28. Miyamasu, M., Yamaguchi, M., Nakajima, T., Misaki, Y., Morita, Y., Matsushima, K., Yamamoto, K., and Hirai, K. (1999). Th1-derived cytokine IFN-gamma is a potent inhibitor of eotaxin synthesis in vitro. Int Immunol 11, 1001-1004.
29. Mochizuki, M., Bartels, J., Mallet, A.I., Christophers, E., and Schröder, J.-M. (1998). IL-4 induces eotaxin: A possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J. Immunol. 160, 60-68.
30. Nakajima, T., Yamada, H., Iikura, M., Miyamasu, M., Izumi, S., Shida, H., Ohta, K., Imai, T., Yoshie, O., Mochizuki, M., Schröder, J.M., Morita, Y., Yamamota, K., and Hirai, K. (1998). Intracellular localization and release of eotaxin from normal eosinophils. FEBS Lett. 434, 226-230.
31. Noso, N., Proost, P., Van Damme, J., and Schröder, J.-M. (1994). Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP-3) attract human eosinophils and desensitize the chemotactic responses towards RANTES. Biochem. Biophys. Res. Commun. 200, 1470-1476.
32. Noso, N., Sticherling, M., Bartels, J., Mallet, A.I., Christophers, E., and Schröder, J.-M. (1996). Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblast. J. Immunol. 156, 1946-1953.
33. Noso, N., Bartels, J., Mallet, A.I., Mochizuki, M., Christophers, E., and Schröder, J.-M. (1998). Delayed production of biologically active O-glycosylated forms of human eotaxin by tumor-necrosis-factor-α-stimulated dermal fibroblasts. Eur. J. Biochem. 253, 114-122.
34. Opdenakker, G., Rudd, P.M., Wormald, M., Dwek, R.A., and Van Damme, J. (1995). Cells regulate the activities of cytokines by glycosylation. FASEB J. 9, 453-457.
35. Owen, W.F., Rothenberg, M.E., Silberstein, D.S., Gasson, J.C., Stevens, R.L., Austen, K.F., and Soberman, R.F. (1987). Regulation of human eosinophil viability, density and functional activity by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J. Exp. Med. 166, 129-137.
36. Petering, H., Hochstetter, R., Kimming, D., Smolarski, R., Kapp, A., and Elsner, J. (1998). Detection of MCP-4 in dermal fibroblasts and its activation of the respiratory burst in human eosinophils. J. Immunol, 160, 555-558.
37. Polentarutti, N., Introna, M., Sozzani, S., Mancinelli, R., Mantovani, G., and Mantovani, A. (1997). Expression of monocyte chemotactic protein-3 in human monocytes and endothelial cells. Eur. Cytokine Netw. 8, 271-274.
38. Ponath, P.D., Qin, S., Ringler, D.J., Clark-Lewis, I., Wang, J., Kassam, N., Smith, H., Shi, X., Gonzalo, J.A., Newman, W., Gutierrez-Ramos, J.C., and Mackay, C.R. (1996). Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97, 604-612.
39. Proost, P., De Meester, I., Schols, D., Struyf, S., Lambeir, A.M., Wuyts, A., Opdenakker, G., De Clercq, E., Scharpe, S., and Van Damme, J. (1998). Amino-terminal truncation of chemokines by CD26/dipeptidylpeptidase IV - Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J. Biol. Chem. 273, 7222-7227.
40. Rothenberg, M.E., Luster, A.D., and Leder, P. (1995). Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc. Natl. Acad. Sci. USA 92, 8960-8964.
41. Rothenberg, M.E., MacLean, J.A., Pearlman, E., Luster, A.D., and Leder, P. (1997). Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med. 185, 785-790.
42. Sallusto, F., Mackay, C.R., and Lanzavecchia, A. (1997). Selective expression of the eotaxin receptor CCR3 by human T helper 2 cels. Science 277, 2005-2007.
43. Sallusto, F., Lenig, D., Mackay, C.R., and Lanzavecchia, A. (1998). Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187, 875-883.
44. Sanz, M.J., Ponath, P.D., Mackay, C.R., Newman, W., Miyasaka, M., Tamatani, T., Flanagan, B.F., Lobb, R.R., Williams, T.J., Nourshargh, S., and Jose, P.F. (1998). Human eotaxin induces alpha 4 and beta 2 integrin-dependent eosinophil accumulation in rat skin in vivo: delayed generation of eotaxin in response to IL-4. J. Immunol. 160, 3569-3576.
45. Schols, D., Proost, P., Struyf, S., Wuyts, A., De Meester, I., Scharpe, S., Van Damme, J., and De Clercq, E. (1998). CD26-processed RANTES (3-68), but not intact RANTES, has potent anti-HIV-1 activity. Antiviral. Res. 39, 175-187.
46. Schröder, J.-M. (1995). Inflammatory mediators and chemoattractants. Clinics in Dermatology 13, 137-150.
47. Schröder, J.-M. (1997). Identification and structural characterization of chemokines in lesional skin material of patients with inflammatory skin disease. Meth. Enzymol. 283, 266-297.
48. Schröder, J.-M., Noso, N., Sticherling, M., and Christophers, E. (1996). Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammation. J. Leuko. Biol. 59, 1-5.
49. Schrum, S., Probst, P., Fleischer, B., and Zipfel, RF. (1996). Synthesis of the CC-chemokine MIP-1α, MIP-1α, and RANTES is associated with a type 1 immune response. J. Immunol. 157, 3598-3604.
50. Schwenk, U., Morita, E., Engel, R., and Schröder, J.-M. (1992). Identification of 5-oxo-15-hydroxy-6,8,11,13-eicosatetraenoic acid as a novel and potent human eosinophil chemotactic eicosanoid. J. Biol. Chem. 267, 12482-12488.
51. Schwenk, U., and Schröder, J.M. (1995). 5-oxo-eicosanoids are potent eosinophil chemotactic factors. J. Biol. Chem. 270, 15029-15036.
52. Spergel, J.M., Mizoguchi, E., Oettgen, H., Bhan, A.K., and Geha, R.S. (1999). Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis: J. Clin. Invest. 103, 1103-1111.
53. Struyf, S., De Meester, I., Scharpe, S., Lenaerts, J.-P., Menten, P., Wang, J.M., Proost, P., and Van Damme, J. (1998). Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor. Eur. J. Immunol. 28, 1262-1271.
54. Teixeira, M.M., Welss, T.N., Lukacs, N.W., Proudfoot, A.E., Kunkel, S.L., Williams, T.J., and Hellewell, P.G. (1997). Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J. Clin. Invest. 100, 1657-1666.
55. Teran, L.M., Mochizuki, M., Bartels, J., Valencia, E.L., Nakajima, T., Hirai, K., and Schröder, J.M. (1999). Th1-andTh2-typecytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am. J. Respir. Cell. Mol. Biol. 20, 777-786.
56. Wang, J.M., Rambaldi, A., Biondi, A., Chen, Z.G., Sanderson, C.J., and Mantovani, A. (1989). Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur. J. Immunol. 19, 701-708.
57. Watanabe, O., Natori, K., Tamari, M., Shiomoto, Y., Kubo, S., and Nakamura, Y. (1999). Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in NOA mouse, a model for atopic dermatitis. J. Hum. Genet. 44, 173-176.
58. Wardlaw, A.J., Moqbel, R., Cromwell, O., and Kay, A.B. (1986). Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J. Clin. Invest. 78, 1701-1706.
59. Yang, Y., Loy, J., Ryseck, R.P., Carrasco, D., and Bravo, R. (1998). Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin. Blood 92, 3912-3923.
60. Ying, S., Taborda-Barata, L., Meng, Q., Humbert, M., and Kay, A.B. (1995). The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. J. Exp. Med. 181, 2153-2159.
61. Zhu, Z., Homer, R.J., Wang, Z., Chen, Q., Geba, G.P., Wang, J., Zhang, Y., and Elias, J.A. (1999). Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnomalities, and eotaxin production. J. Clin. Invest. 103, 779-788.